Drug Enforcement Administration April 14, 2016 – Federal Register Recent Federal Regulation Documents

Manufacturer of Controlled Substances Registration: Stepan Company
Document Number: 2016-08576
Type: Notice
Date: 2016-04-14
Agency: Drug Enforcement Administration, Department of Justice
Stepan Company applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Stepan Company registration as a manufacturer of those controlled substances.
Rezik A. Saqer, M.D.; Decision and Order
Document Number: 2016-08572
Type: Notice
Date: 2016-04-14
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Patheon API Manufacturing, Inc.
Document Number: 2016-08569
Type: Notice
Date: 2016-04-14
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I
Document Number: 2016-08566
Type: Rule
Date: 2016-04-14
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final order, the Administrator of the Drug Enforcement Administration places the substance AH-7921 (Systematic IUPAC Name: 3,4-dichloro-N- [(1dimethylamino)cyclohexylmethyl]benzamide), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, into schedule I of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act and is required in order for the United States to discharge its obligations under the Single Convention on Narcotic Drugs, 1961. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, AH-7921.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.